ReAlta Life Sciences, Inc. is a fledgling biotechnology firm committed to exploiting the potential of the immune system to tackle critical medical necessities. In pursuit of its mission, ReAlta has engineered an innovative category of medications with distinctive multi-faceted healing capabilities that recalibrate complement and inflammatory processes. The establishment was formed in the latter part of 2018 and is situated in Norfolk, Virginia.